{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:23:52Z","timestamp":1791404632462,"version":"4.3.3"},"reference-count":226,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jconrel.2017.09.003","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T19:46:55Z","timestamp":1504640815000},"page":"247-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":239,"special_numbering":"C","title":["Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment"],"prefix":"10.1016","volume":"264","author":[{"given":"Chun Y.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Al-Salami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7087-7957","authenticated-orcid":false,"given":"Crispin R.","family":"Dass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.09.003_bb0005","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2015"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2337\/dc13-S067","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.12816\/0003082","article-title":"The role of oxidative stress and antioxidants in diabetic complications","volume":"12","author":"Matough","year":"2012","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0020","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.diabres.2011.10.040","article-title":"The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults","volume":"94","author":"Guariguata","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/07435800701743810","article-title":"Pathogenesis of type 2 diabetes","volume":"32","author":"Stumvoll","year":"2007","journal-title":"Endocr. Res."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1152\/physrev.00024.2006","article-title":"Disordered lipid metabolism and the pathogenesis of insulin resistance","volume":"87","author":"Savage","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3949\/ccjm.78a.10051","article-title":"Insulin treatment for type 2 diabetes: when to start, which to use","volume":"78","author":"Hamaty","year":"2011","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0045","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra0808284","article-title":"Genetics of type 1A diabetes","volume":"360","author":"Concannon","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2012.07.035","article-title":"Chitosan-zinc-insulin complex incorporated thermosensitive polymer for controlled delivery of basal insulin in vivo","volume":"163","author":"Oak","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0055","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.carbpol.2013.06.063","article-title":"Ultrasonication of insulin-loaded microgel particles produced by internal gelation: Impact on particle's size and insulin bioactivity","volume":"98","author":"Santos","year":"2013","journal-title":"Carbohydr Polym."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diacare.23.5.583","article-title":"Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes","volume":"23","author":"Raskin","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.diabres.2004.03.003","article-title":"Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes","volume":"66","author":"Raslova","year":"2004","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003088-200847010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of insulin glulisine","volume":"47","author":"Becker","year":"2008","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/14656566.6.4.643","article-title":"Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes","volume":"6","author":"Garg","year":"2005","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0080","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.2337\/diabetes.49.12.2142","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro","volume":"49","author":"Lepore","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0085","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","article-title":"The treat-to-target trial, randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients","volume":"26","author":"Riddle","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0090","doi-asserted-by":"crossref","first-page":"559","DOI":"10.7326\/0003-4819-143-8-200510180-00006","article-title":"Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial","volume":"143","author":"Heine","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0095","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1023\/B:PHAM.0000036926.54824.37","article-title":"The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin","volume":"21","author":"Havelund","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2337\/diacare.3.5.623","article-title":"Intermediate-acting insulin preparations: NPH and lente","volume":"3","author":"Deckert","year":"1980","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0105","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1021\/acs.molpharmaceut.6b00188","article-title":"Effective enhancement of hypoglycemic effect of insulin by liver-targeted nanoparticles containing cholic acid-modified chitosan derivative","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.diabres.2011.07.023","article-title":"Acanthosis nigricans as a local cutaneous side effect of repeated human insulin injections","volume":"94","author":"Buzasi","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00128071-200304100-00001","article-title":"Skin-related complications of insulin therapy","volume":"4","author":"Richardson","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ph.47.030185.002041","article-title":"The nature and regulation of the insulin receptor: structure and function","volume":"47","author":"Czech","year":"1985","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0125","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.drudis.2012.03.019","article-title":"An overview of natural polymers for oral insulin delivery","volume":"17","author":"Sonia","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.addr.2013.04.006","article-title":"Oral delivery of proteins by biodegradable nanoparticles","volume":"65","author":"Bakhru","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0135","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/diab.21.12.1131","article-title":"The structure of insulin","volume":"21","author":"Hodgkin","year":"1972","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0140","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature01667","article-title":"Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction","volume":"423","author":"Puigserver","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0145","doi-asserted-by":"crossref","first-page":"31484","DOI":"10.1074\/jbc.M109.033936","article-title":"Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin","volume":"284","author":"Liu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/01.HYP.19.1_Suppl.I78","article-title":"Effects of insulin on renal sodium excretion","volume":"19","author":"Gupta","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0155","first-page":"174","article-title":"Insulin-mediated potassium uptake is normal in uremic and healthy subjects","volume":"246","author":"Alvestrand","year":"1984","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-4899-1236-7_11","article-title":"Insulin structure and stability","volume":"5","author":"Brange","year":"1993","journal-title":"Pharm. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0165","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jmb.2004.07.033","article-title":"A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer","volume":"342","author":"Zoete","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0170","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/js960297s","article-title":"Toward understanding insulin fibrillation","volume":"86","author":"Brange","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0175","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/372746a0","article-title":"Crystal structure of the tyrosine kinase domain of the human insulin receptor","volume":"372","author":"Hubbard","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0180","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/1872211308666140701093351","article-title":"Recent patents on oral insulin delivery","volume":"8","author":"Navgire","year":"2014","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0185","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/jphp.12607","article-title":"Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities","volume":"68","author":"Wong","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/10010065","article-title":"Polymeric particulates to improve oral bioavailability of peptide drugs","volume":"10","author":"Delie","year":"2005","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0195","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2337\/diacare.3.2.270","article-title":"\"Normal\" insulin secretion: the goal of artificial insulin delivery systems?","volume":"3","author":"Eaton","year":"1980","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0200","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/152091502760306544","article-title":"Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2","volume":"4","author":"Clement","year":"2002","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0205","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1389201015666140915151319","article-title":"Intestinal uptake of insulin nanoparticles: facts or myths?","volume":"15","author":"Lopes","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0210","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","article-title":"Biodegradable nanoparticles for drug delivery and targeting","volume":"6","author":"Hans","year":"2002","journal-title":"Curr. Opin. Solid St. Mater. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0215","first-page":"1","article-title":"Types of nanocarriers-formulation methods and applications","volume":"9","author":"Wakaskar","year":"2017","journal-title":"J. Bioequiv."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0016-5085(70)80092-0","article-title":"Surface structure of intestinal epithelium","volume":"58","author":"Balcerzak","year":"1970","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0225","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer's-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0230","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM199707173370307","article-title":"Insulin lispro","volume":"337","author":"Holleman","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0235","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.micinf.2005.04.003","article-title":"The role of enterocytes in the intestinal barrier function and antigen uptake","volume":"7","author":"Snoeck","year":"2005","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of surface properties on nanoparticle-cell interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","article-title":"Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake","volume":"82","author":"Sahoo","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0250","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0026-895X(25)09229-6","article-title":"Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides","volume":"41","author":"Bennett","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0260","first-page":"987","article-title":"Lectins are sensitive tools for defining the differentiation programs of mouse gut epithelial cell lineages","volume":"266","author":"Falk","year":"1994","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2016.07.036","article-title":"Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles - important step towards effective mucosal vaccines","volume":"249","author":"Ma\u0161ek","year":"2017","journal-title":"J. Contr. Rel."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0270","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/adma.201201800","article-title":"Mucus penetrating nanoparticles: bio tool and method of drug and gene delivery","volume":"24","author":"Ensign","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0275","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/anie.201006849","article-title":"Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus","volume":"50","author":"Yang","year":"2011","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0280","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","article-title":"Measurement of gastrointestinal pH profiles in normal ambulant human subjects","volume":"29","author":"Evans","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0285","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0378-5173(84)90191-1","article-title":"The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet)","volume":"21","author":"Davis","year":"1984","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(84)90101-7","article-title":"Pharmacokinetics and in vivo scintigraphic monitoring of a sustained release acetylsalicylic acid formulation","volume":"18","author":"Wilson","year":"1984","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0295","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/00365528609011099","article-title":"Assessment of orocoecal transit time by means of a hydrogen (H2) breath test as compared with a radiologic control method","volume":"21","author":"Armbrecht","year":"1986","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(96)01586-6","article-title":"The challenge of proteolytic enzymes in intestinal peptide delivery","volume":"46","author":"Langguth","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0305","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s11095-005-6137-z","article-title":"Region-dependent role of the mucous\/glycocalyx layers in insulin permeation across rat small intestinal membrane","volume":"22","author":"Aoki","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1208\/aapsj080112","article-title":"Cytochrome P450s and other enzymes in drug metabolism and toxicity","volume":"8","author":"Guengerich","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0315","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejps.2015.02.014","article-title":"Improved oral therapeutic potential of nanoencapsulated cryptdin formulation against Salmonella infection","volume":"72","author":"Rishi","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0320","first-page":"4081","article-title":"Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism","volume":"10","author":"Mahidhara","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0325","first-page":"113","article-title":"Preparation of polyelectrolyte nanocomplexes containing recombinant human hepatocyte growth factor as potential oral carriers for liver regeneration","volume":"811","author":"Ribeiro","year":"2012"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0330","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1021\/mp400184v","article-title":"In vitro and in vivo ealuation of osteoporosis therapeutic peptide PTH 1-34 loaded PEGylated chitosan nanoparticles","volume":"10","author":"Narayanan","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0335","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1016\/j.biomaterials.2014.01.020","article-title":"Treatment of chemotherapy-induced neutropenia in a rat model by using multiple daily doses of oral administration of G-CSF-containing nanoparticles","volume":"35","author":"Su","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0340","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1208\/s12249-014-0201-0","article-title":"Serratiopeptidase loaded chitosan nanoparticles by polyelectrolyte complexation: in vitro and in vivo evaluation","volume":"16","author":"Mali","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0345","first-page":"339","article-title":"Oral polymeric N-acetyl-d-glucosamine and osteoarthritis","volume":"101","author":"Rubin","year":"2001","journal-title":"J. Am. Osteopath. Assoc."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0350","series-title":"Chitosan-based Systems for Biopharmaceuticals: Delivery, Targeting, and Polymer Therapeutics Chichester, Chichester, West Sussex","author":"John Wiley & Sons","year":"2011"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0355","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.biomaterials.2011.03.056","article-title":"Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening","volume":"32","author":"Yeh","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0360","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/mp200572t","article-title":"Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations","volume":"9","author":"Sonaje","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0365","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0168-3659(94)90072-8","article-title":"Mechanisms of absorption enhancement and tight junction regulation","volume":"29","author":"Hochman","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0370","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1016\/j.biomaterials.2013.08.048","article-title":"Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0375","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejpb.2009.06.004","article-title":"Formulation and characterization of an oily-based system for oral delivery of insulin","volume":"73","author":"Elsayed","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0380","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","article-title":"Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery","volume":"33","author":"Su","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0385","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.biomaterials.2008.12.066","article-title":"In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery","volume":"30","author":"Sonaje","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0390","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/bm0607776","article-title":"Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery","volume":"8","author":"Lin","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0395","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2012.11.011","article-title":"Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery","volume":"169","author":"Chuang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0400","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2016.12.018","article-title":"Safety and efficacy of self-assembling bubble carriers stabilized with sodium dodecyl sulfate for oral delivery of therapeutic proteins","volume":"259","author":"Lin","year":"2017","journal-title":"J. Contr. Rel."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0405","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijpharm.2007.11.052","article-title":"Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods","volume":"355","author":"Sadeghi","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0410","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2008.08.020","article-title":"Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs","volume":"132","author":"Lin","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0415","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1021\/bm049312a","article-title":"Preparation of nanoparticles composed of chitosan\/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells","volume":"6","author":"Lin","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0430","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0169-409X(01)00231-9","article-title":"Oral drug absorption enhancement by chitosan and its derivatives","volume":"52","author":"Thanou","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0435","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jconrel.2013.05.006","article-title":"Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats","volume":"172","author":"Chuang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0440","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.biomaterials.2010.01.042","article-title":"Enteric-coated capsules filled with freeze-dried chitosan\/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0445","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0450","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/jps.20364","article-title":"Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and\/or immobilization in a glassy matrix?","volume":"94","author":"Chang","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0455","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/bm900035u","article-title":"Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles","volume":"10","author":"Cui","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0460","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nano.2009.04.007","article-title":"Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method","volume":"6","author":"Avadi","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0465","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2010.12.007","article-title":"Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery","volume":"42","author":"Makhlof","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0470","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2010.01.022","article-title":"Thiolated trimethyl chitosan nanocomplexes as gene carriers with high in vitro and in vivo transfection efficiency","volume":"144","author":"Zhao","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0475","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/ar200234q","article-title":"pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications","volume":"45","author":"Sung","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0480","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1021\/bc800076n","article-title":"Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation","volume":"19","author":"Mi","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0485","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.12.008","article-title":"Efficient mucus permeation and tight junction opening by dissociable \u201cmucus-inert\u201d agent coated trimethyl chitosan nanoparticles for oral insulin delivery","volume":"222","author":"Liu","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0490","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.carbpol.2016.10.021","article-title":"Mechanism of surface charge triggered intestinal epithelial tight junction opening upon chitosan nanoparticles for insulin oral delivery","volume":"157","author":"Wang","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0495","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijpharm.2007.12.037","article-title":"Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies","volume":"356","author":"Bayat","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0500","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0505","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cSlip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0510","doi-asserted-by":"crossref","first-page":"19268","DOI":"10.1073\/pnas.0905998106","article-title":"Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier","volume":"106","author":"Tang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0515","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2005.12.015","article-title":"Chitosan\u2013PEG nanocapsules as new carriers for oral peptide delivery: effect of chitosan pegylation degree","volume":"111","author":"Prego","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0520","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijpharm.2007.05.015","article-title":"Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles","volume":"342","author":"Jintapattanakit","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0525","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.eurpolymj.2007.03.042","article-title":"Synthesis and characterization of PEG modified N-trimethylaminoethylmethacrylate chitosan nanoparticles","volume":"43","author":"Zhu","year":"2007","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0530","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1021\/nn201624c","article-title":"Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size","volume":"5","author":"Oh","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0535","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2567.2002.01514.x","article-title":"Redistribution of the sheep neonatal Fc receptor in the mammary gland around the time of parturition in ewes and its localization in the small intestine of neonatal lambs","volume":"107","author":"Mayer","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0540","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biomaterials.2011.10.075","article-title":"Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport","volume":"33","author":"Jin","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0545","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1021\/mp400685v","article-title":"Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles","volume":"11","author":"Zhang","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0550","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ijpharm.2015.10.078","article-title":"Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin","volume":"496","author":"Zhang","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0555","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3892\/ijo_00000293","article-title":"Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer","volume":"34","author":"Seymour","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0560","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jconrel.2003.12.017","article-title":"Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats","volume":"95","author":"Krauland","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0565","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.biomaterials.2009.06.055","article-title":"Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery","volume":"30","author":"Yin","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0570","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1517\/17425247.2010.510830","article-title":"Emerging trend in nano-engineered polyelectrolyte-based surrogate carriers for delivery of bioactives","volume":"7","author":"Shukla","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0575","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.msec.2013.09.045","article-title":"Layer-by-layer deposited nano- and micro-assemblies for insulin delivery: a review","volume":"34","author":"Yoshida","year":"2014","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0580","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2006.05.062","article-title":"Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption","volume":"324","author":"Fan","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0585","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.actbio.2015.12.017","article-title":"Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: a mucoadhesive and pH responsive carrier for improved oral delivery of insulin","volume":"31","author":"Verma","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0590","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1021\/bm0503165","article-title":"Exploiting the vitamin B12 pathway to enhance oral drug delivery via polymeric micelles","volume":"6","author":"Francis","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0595","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jps.20520","article-title":"Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin","volume":"95","author":"Mao","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0600","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijpharm.2016.01.022","article-title":"Insulin loaded mucus permeating nanoparticles: addressing the surface characteristics as feature to improve mucus permeation","volume":"500","author":"Pereira-de-Sousa","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0605","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.talanta.2009.06.054","article-title":"Glucose biosensor based on immobilization of glucose oxidase in platinum nanoparticles\/graphene\/chitosan nanocomposite film","volume":"80","author":"Wu","year":"2009","journal-title":"Talanta"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0610","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/jps.22463","article-title":"Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release","volume":"100","author":"Wu","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0615","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/pharmaceutics8040030","article-title":"Cross-linked dependency of boronic acid-conjugated chitosan nanoparticles by diols for sustained insulin release","volume":"8","author":"Siddiqui","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0620","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/pharmaceutics5010069","article-title":"Correlating physicochemical properties of boronic acid-chitosan conjugates to glucose adsorption sensitivity","volume":"5","author":"Asantewaa","year":"2012","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0625","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/09205063.2016.1246289","article-title":"Development of shell cross-linked nanoparticles based on boronic acid-related reactions for self-regulated insulin delivery","volume":"28","author":"Wang","year":"2017","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0630","first-page":"1","article-title":"Multiboronic acid-conjugated chitosan scaffolds with glucose selectivity to insulin release","author":"Siddiqui","year":"2017","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0635","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrd4477","article-title":"Managing diabetes with nanomedicine: challenges and opportunities","volume":"14","author":"Veiseh","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0640","doi-asserted-by":"crossref","first-page":"8032","DOI":"10.1039\/c3cs60148j","article-title":"Selective sensing of saccharides using simple boronic acids and their aggregates","volume":"42","author":"Wu","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0645","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1016\/S0040-4020(02)00489-1","article-title":"A detailed examination of boronic acid\u2013diol complexation","volume":"58","author":"Springsteen","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0650","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(02)00486-6","article-title":"Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo","volume":"249","author":"Pan","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0655","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/jps.10149","article-title":"Formulation pH modulates the interaction of insulin with chitosan nanoparticles","volume":"91","author":"Ma","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0660","first-page":"1051","article-title":"Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres","volume":"23","author":"Pan","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0665","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2004.12.025","article-title":"Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats","volume":"293","author":"Ma","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0670","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1021\/bm060065f","article-title":"Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization","volume":"7","author":"Qian","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0675","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2006.06.019","article-title":"Cyclodextrin\u2013insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery","volume":"325","author":"Sajeesh","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0680","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1021\/ma060230j","article-title":"Formation of new glucomannan\u2212chitosan nanoparticles and study of their ability to associate and deliver proteins","volume":"39","author":"Alonso-Sande","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0685","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpharm.2007.03.005","article-title":"Chitosan\/cyclodextrin nanoparticles as macromolecular drug delivery system","volume":"340","author":"Krauland","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1088\/0957-4484\/18\/10\/105102","article-title":"Novel nanoparticles for oral insulin delivery via the paracellular pathway","volume":"18","author":"Lin","year":"2007","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0695","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.biomaterials.2007.01.005","article-title":"Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles","volume":"28","author":"Bravo-Osuna","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0700","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1002\/jps.21783","article-title":"The role of mucoadhesion of trimethyl chitosan and PEGylated trimethyl chitosan nanocomplexes in insulin uptake","volume":"98","author":"Jintapattanakit","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0705","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1002\/adfm.201001014","article-title":"Self-assembled pH-sensitive nanoparticles: a platform for oral delivery of protein drugs","volume":"20","author":"Sonaje","year":"2010","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0710","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1016\/j.biomaterials.2010.05.042","article-title":"Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0715","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s13233-010-0714-7","article-title":"Insulin-incorporated chitosan nanoparticles based on polyelectrolyte complex formation","volume":"18","author":"Nam","year":"2010","journal-title":"Macromol. Res."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0720","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1208\/s12249-011-9716-9","article-title":"Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan","volume":"12","author":"Mahjub","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0725","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.msec.2012.09.001","article-title":"Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model","volume":"33","author":"Mukhopadhyay","year":"2013","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0730","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.msec.2014.10.070","article-title":"Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes","volume":"46","author":"Moghassemi","year":"2015","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0735","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1021\/acs.molpharmaceut.6b00561","article-title":"Dependence of intestinal absorption profile of insulin on carrier morphology composed of beta-cyclodextrin-grafted chitosan","volume":"13","author":"Daimon","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0740","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2016.05.015","article-title":"Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates","volume":"233","author":"Sheng","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.04.017","article-title":"Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review","volume":"114","author":"George","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0750","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0169-409X(97)00124-5","article-title":"Protein release from alginate matrices","volume":"31","author":"Wee","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0755","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s11095-007-9367-4","article-title":"Alginate\/chitosan nanoparticles are effective for oral insulin delivery","volume":"24","author":"Sarmento","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0760","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1166\/jnn.2007.609","article-title":"Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation","volume":"7","author":"Sarmento","year":"2007","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0765","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejpb.2006.09.005","article-title":"Probing insulin's secondary structure after entrapment into alginate\/chitosan nanoparticles","volume":"65","author":"Sarmento","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0770","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijbiomac.2013.03.064","article-title":"Oral delivery of insulin from alginate\/chitosan crosslinked by glutaraldehyde","volume":"58","author":"Tahtat","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0775","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijpharm.2010.04.006","article-title":"Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate\/chitosan nanoparticles","volume":"393","author":"Zhang","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0780","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1155\/2013\/591751","article-title":"Development and evaluation of insulin incorporated nanoparticles for oral administration","volume":"2013","author":"Prusty","year":"2013","journal-title":"ISRN Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0785","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1021\/bm0703923","article-title":"Oral bioavailability of insulin contained in polysaccharide nanoparticles","volume":"8","author":"Sarmento","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0790","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejps.2006.12.007","article-title":"Nanoparticulate delivery system for insulin: design, characterization and in vitro\/in vivo bioactivity","volume":"30","author":"Reis","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0795","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpb.2009.06.002","article-title":"Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin","volume":"73","author":"Woitiski","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0800","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejps.2010.08.009","article-title":"Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles","volume":"41","author":"Woitiski","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0805","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2016.04.012","article-title":"Dual chitosan\/albumin-coated alginate\/dextran sulfate nanoparticles for enhanced oral delivery of insulin","volume":"232","author":"Lopes","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0810","first-page":"5865","article-title":"Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification\/internal gelation","volume":"10","author":"Lopes","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0815","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejpb.2016.11.037","article-title":"In vivo biodistribution of antihyperglycemic biopolymer-based nanoparticles for the treatment of type 1 and type 2 diabetes","volume":"113","author":"Lopes","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2006.02.008","article-title":"Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies","volume":"66","author":"Sarmento","year":"2006","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0825","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(03)00055-3","article-title":"Insulin containing polyethylenimine-dextran sulfate nanoparticles","volume":"255","author":"Tiyaboonchai","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0830","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.colsurfb.2006.09.012","article-title":"Development and characterization of new insulin containing polysaccharide nanoparticles","volume":"53","author":"Sarmento","year":"2006","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0835","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10989-005-9010-3","article-title":"Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers","volume":"12","author":"Sarmento","year":"2006","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0840","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2006.12.003","article-title":"A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin","volume":"117","author":"Chalasani","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0845","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2007.05.019","article-title":"Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles","volume":"122","author":"Chalasani","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0850","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10717540801905165","article-title":"Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery","volume":"15","author":"Reis","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0855","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.actbio.2009.03.007","article-title":"Colloidal carrier integrating biomaterials for oral insulin delivery: influence of component formulation on physicochemical and biological parameters","volume":"5","author":"Woitiski","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0860","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1021\/la303860t","article-title":"Ternary interpolyelectrolyte complexes insulin-poly(methylaminophosphazene)-dextran sulfate for oral delivery of insulin","volume":"29","author":"Burova","year":"2013","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0865","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/erm.09.15","article-title":"Current advances in research and clinical applications of PLGA-based nanotechnology","volume":"9","author":"Lu","year":"2009","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0870","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2006.05.013","article-title":"Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation","volume":"114","author":"Cui","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0875","first-page":"3049","article-title":"Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin","volume":"6","author":"Sun","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0880","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1773-2247(08)50047-5","article-title":"A novel insulin-sodium oleate complex for oral administration: preparation, characterization and in vivo evaluation","volume":"18","author":"Sun","year":"2008","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0885","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/02652040903515490","article-title":"Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation","volume":"27","author":"Sun","year":"2010","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0890","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2015.02.055","article-title":"Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin","volume":"484","author":"Yu","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0895","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/0883911507088276","article-title":"Preparation and in vitro evaluation of linear and star-branched PLGA nanoparticles for insulin delivery","volume":"23","author":"Davaran","year":"2008","journal-title":"J. Bioact. Compat. Polym."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0900","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jps.20750","article-title":"Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery","volume":"96","author":"Cui","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.12.055","article-title":"HP55-coated capsule containing PLGA\/RS nanoparticles for oral delivery of insulin","volume":"425","author":"Wu","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0910","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1021\/acsami.5b03555","article-title":"N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption","volume":"7","author":"Sheng","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0915","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejps.2012.01.002","article-title":"Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration","volume":"45","author":"Zhang","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0920","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2217\/nnm.12.31","article-title":"Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin","volume":"7","author":"Jain","year":"2012","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0925","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2008.08.001","article-title":"Usefulness of cell-penetrating peptides to improve intestinal insulin absorption","volume":"132","author":"Kamei","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0930","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2013.03.033","article-title":"Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin","volume":"448","author":"Liu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0935","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s11051-012-1219-4","article-title":"Concanavalin A conjugated biodegradable nanoparticles for oral insulin delivery","volume":"14","author":"Hurkat","year":"2012","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0940","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.colsurfb.2015.01.035","article-title":"Surface engineered and ligand anchored nanobioconjugate: an effective therapeutic approach for oral insulin delivery in experimental diabetic rats","volume":"127","author":"Sharma","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0945","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00592-015-0714-3","article-title":"l-Valine appended PLGA nanoparticles for oral insulin delivery","volume":"52","author":"Jain","year":"2015","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0950","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1002\/anie.201509183","article-title":"Polymeric nanoparticles amenable to simultaneous installation of exterior targeting and interior therapeutic proteins","volume":"55","author":"Zhu","year":"2016","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0955","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1081\/DDC-100102197","article-title":"Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method","volume":"25","author":"Barichello","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0960","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2012.08.024","article-title":"In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles","volume":"437","author":"Reix","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0965","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/cbdd.12318","article-title":"Synthesis, characterization, and in vitro studies of PLGA-PEG nanoparticles for oral insulin delivery","volume":"84","author":"Hosseininasab","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0970","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2007.04.004","article-title":"Vesicles from Pluronic\/poly(lactic acid) block copolymers as new carriers for oral insulin delivery","volume":"120","author":"Xiong","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0975","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3007049","article-title":"Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery","volume":"5","author":"Pridgen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0980","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2567.1997.00326.x","article-title":"Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells","volume":"92","author":"Israel","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0985","doi-asserted-by":"crossref","first-page":"25444","DOI":"10.1021\/acsami.6b08183","article-title":"Enhanced oral delivery of protein drugs using zwitterion-functionalized nanoparticles to overcome both the diffusion and absorption barriers","volume":"8","author":"Shan","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2017.09.003_bb0990","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2009.04.014","article-title":"The complexation between novel comb shaped amphiphilic polyallylamine and insulin-towards oral insulin delivery","volume":"376","author":"Thompson","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb0995","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2009.09.018","article-title":"The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin-towards oral insulin delivery","volume":"383","author":"Thompson","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1000","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s11095-010-0345-x","article-title":"Uptake and transport of novel amphiphilic polyelectrolyte-insulin nanocomplexes by Caco-2 cells-towards oral insulin","volume":"28","author":"Thompson","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/mp400493b","article-title":"Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery","volume":"11","author":"Zhu","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1010","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/acsnano.5b00028","article-title":"Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin","volume":"9","author":"Shan","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.09.003_bb1015","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1208\/s12249-016-0594-z","article-title":"Eudragit S100-coated chitosan nanoparticles co-loading tat for enhanced oral colon absorption of insulin","volume":"18","author":"Chen","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2017.09.003_bb1020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/la051982u","article-title":"Gold nanopartncles as carriers for efficient transmucosal insulin delivery","volume":"22","author":"Joshi","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2017.09.003_bb1025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijbiomac.2013.10.026","article-title":"Chondroitin sulfate-capped gold nanoparticles for the oral delivery of insulin","volume":"63","author":"Cho","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1030","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","article-title":"Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin","volume":"24","author":"Bhumkar","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijpharm.2013.06.051","article-title":"Preparation, characterization, and evaluation in vivo of Ins-SiO(2)-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin","volume":"454","author":"Zhao","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1040","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1021\/bm100659p","article-title":"Nanoencapsulation of insulin into zirconium phosphate for oral delivery applications","volume":"11","author":"Diaz","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.09.003_bb1045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11705-013-1306-9","article-title":"Overcoming oral insulin delivery barriers: application of cell penetrating peptide and silica-based nanoporous composites","volume":"7","author":"He","year":"2013","journal-title":"Front. Chem. Sci. Eng."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2006.10.023","article-title":"Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats","volume":"117","author":"Damge","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.003_bb1055","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jps.21874","article-title":"Poly(epsilon-caprolactone)\/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes","volume":"99","author":"Damge","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1081\/DDC-200047802","article-title":"Formulation of insulin-loaded polymeric nanoparticles using response surface methodology","volume":"31","author":"Attivi","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2013.01.017","article-title":"Oral insulin delivery in rats by nanoparticles prepared with non-toxic solvents","volume":"443","author":"Viehof","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ijpharm.2014.07.049","article-title":"Preparation and characterization of PEG-coated silica nanoparticles for oral insulin delivery","volume":"473","author":"Andreani","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1075","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1080\/10717544.2016.1209796","article-title":"pH responsive cylindrical MSN for oral delivery of insulin-design, fabrication and evaluation","volume":"23","author":"Guha","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.colsurfb.2012.10.043","article-title":"Preparation of amphiphilic hollow carbon nanosphere loaded insulin for oral delivery","volume":"103","author":"Ganeshkumar","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.09.003_bb1085","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/mabi.201300515","article-title":"Thiolated eudragit-based nanoparticles for oral insulin delivery: preparation, characterization, and evaluation using intestinal epithelial cells in vitro","volume":"14","author":"Zhang","year":"2014","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.phrs.2016.05.016","article-title":"Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats","volume":"110","author":"Salvioni","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1095","first-page":"743","article-title":"Oral insulin delivery by means of solid lipid nanoparticles","volume":"2","author":"Sarmento","year":"2007","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.003_bb1100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13346-011-0023-5","article-title":"Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin","volume":"1","author":"Fonte","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.carbpol.2014.04.048","article-title":"Decanoic acid grafted oligochitosan nanoparticles as a carrier for insulin transport in the gastrointestinal tract","volume":"111","author":"Du","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.07.026","article-title":"Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin","volume":"327","author":"Zhang","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1115","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.xphs.2016.02.018","article-title":"Methocel-lipid hybrid nanocarrier for efficient oral insulin delivery","volume":"105","author":"Boushra","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1120","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijpharm.2016.07.016","article-title":"Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery","volume":"511","author":"Boushra","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2007.03.009","article-title":"Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization","volume":"340","author":"Liu","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.003_bb1130","first-page":"574","article-title":"Novel solid lipid nanoparticles as carriers for oral administration of insulin","volume":"64","author":"Zhang","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2017.09.003_bb1135","first-page":"3333","article-title":"Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin","volume":"7","author":"Zhang","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.003_bb1140","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2147\/IJN.S96146","article-title":"Self-assembled lecithin\/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation","volume":"11","author":"Liu","year":"2016","journal-title":"Int. J. Nanomedicine"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T15:52:00Z","timestamp":1750866720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917308283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":226,"alternative-id":["S0168365917308283"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.003","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}